362 related articles for article (PubMed ID: 22480803)
1. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy.
Yarnitsky D; Granot M; Nahman-Averbuch H; Khamaisi M; Granovsky Y
Pain; 2012 Jun; 153(6):1193-1198. PubMed ID: 22480803
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine vs. placebo in patients with painful diabetic neuropathy.
Goldstein DJ; Lu Y; Detke MJ; Lee TC; Iyengar S
Pain; 2005 Jul; 116(1-2):109-18. PubMed ID: 15927394
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.
Raskin J; Pritchett YL; Wang F; D'Souza DN; Waninger AL; Iyengar S; Wernicke JF
Pain Med; 2005; 6(5):346-56. PubMed ID: 16266355
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine for the management of diabetic peripheral neuropathic pain: response profile.
Pritchett YL; McCarberg BH; Watkin JG; Robinson MJ
Pain Med; 2007; 8(5):397-409. PubMed ID: 17661853
[TBL] [Abstract][Full Text] [Related]
8. Can topical duloxetine be used for neuropathic pain?
Hsu YC; Tzeng NS
Med Hypotheses; 2014 Feb; 82(2):175-6. PubMed ID: 24332447
[TBL] [Abstract][Full Text] [Related]
9. The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy.
Chen SY; Wu N; Boulanger L; Fraser KA; Zhao Y
Pain Pract; 2010; 10(6):530-9. PubMed ID: 20412505
[TBL] [Abstract][Full Text] [Related]
10. ACP Journal Club. Review: In neuropathy, fibromyalgia, or chronic pain, duloxetine reduces pain but increases adverse events.
Engel CC
Ann Intern Med; 2014 Apr; 160(8):JC12. PubMed ID: 24733217
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
Wu EQ; Birnbaum HG; Mareva MN; Le TK; Robinson RL; Rosen A; Gelwicks S
J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.
Kajdasz DK; Iyengar S; Desaiah D; Backonja MM; Farrar JT; Fishbain DA; Jensen TS; Rowbotham MC; Sang CN; Ziegler D; McQuay HJ
Clin Ther; 2007; 29 Suppl():2536-46. PubMed ID: 18164920
[TBL] [Abstract][Full Text] [Related]
13. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Smith EM; Pang H; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Fadul CE; Knox C; Le-Lindqwister N; Gilman PB; Shapiro CL;
JAMA; 2013 Apr; 309(13):1359-67. PubMed ID: 23549581
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine reduces morphine requirements after knee replacement surgery.
Ho KY; Tay W; Yeo MC; Liu H; Yeo SJ; Chia SL; Lo NN
Br J Anaesth; 2010 Sep; 105(3):371-6. PubMed ID: 20573635
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects.
Prescrire Int; 2006 Oct; 15(85):168-72. PubMed ID: 17121211
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain.
Yoneda S; Kasai E; Matsuo M; Tamano R; Sakurai Y; Asaki T; Fujita M
Neurosci Lett; 2020 Jun; 729():134990. PubMed ID: 32315711
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.
Raskin J; Wang F; Pritchett YL; Goldstein DJ
Pain Med; 2006; 7(5):373-85. PubMed ID: 17014595
[TBL] [Abstract][Full Text] [Related]
19. A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy.
Majdinasab N; Kaveyani H; Azizi M
Drug Des Devel Ther; 2019; 13():1985-1992. PubMed ID: 31354243
[No Abstract] [Full Text] [Related]
20. Review of duloxetine in the management of diabetic peripheral neuropathic pain.
Smith T; Nicholson RA
Vasc Health Risk Manag; 2007; 3(6):833-44. PubMed ID: 18200804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]